News Agencies Feed 

HEALTHCARE

KSrelief provides emergency food aid to Beirut blast victims’ families
August 10, 2020

BEIRUT — King Salman Humanitarian Aid and Relief Center (KSrelief) provided on Sunday emergency food assistance to families of victims of Beirut's port explosion, which resulted in great human and material losses.

The assistance included distributing food baskets, bread and cartons of dates and milk, benefiting 500 families. This comes within the framework of the urgent Saudi assistance being provided to victims of Beirut's port explosion....

Continue Reading >

Saudi Arabia launches clinical trial for Chinese COVID-19 vaccine
August 10, 2020

The Saudi ministry of health has announced the launch of clinical trials for a vaccine against the coronavirus (COVID-19), as part of cooperation with a Chinese company.

According to the Saudi Press Agency (SPA), the third phase will conduct clinical studies in different countries, including Saudi Arabia, and will be applied to large numbers of volunteers.

The"...

Continue Reading >

Saudi Arabia records more recoveries than new cases
August 9, 2020

RIYADH — Saudi Arabia recorded 1,467 new cases of the novel coronavirus, bringing the total confirmed infections in the Kingdom to 287,262, the ministry of health announced on Saturday.

Thirty-seven people died due to complications caused by the virus, bringing the COVID-19 death toll to 3,130.

The total number of recoveries rose to 250,440 after 1,492 people recovered, the ministry spokesman was quoted by Saudi Press Agency (SPA)"...

Continue Reading >

Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening
August 6, 2020

Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced today that it has received 510(k) clearance (K200667) by the U.S. Food & Drug Administration (FDA) to market its EyeArt® autonomous AI System for diabetic retinopathy, a leading cause of blindness among American adults. EyeArt is indicated for use by healthcare providers to automatically detect more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR) in eyes of adults diagnosed with diabetes who have not been previously diagnosed with more than mild diabetic retinopathy. EyeArt is the first FDA cleared autonomous AI technology that can detect both mtmDR and vtDR in one test, in primary care and eye care settings. In addition, EyeArt is also the first FDA cleared autonomous AI technology that has diagnostic outputs for each eye of a patient. Diabetic retinopathy......

Continue Reading >

Vifor Pharma Group Reports Continued Growth in H1 2020
August 6, 2020

  • Net sales and EBITDA continued to grow in H1 2020 despite challenging market conditions due to COVID-19
  • Ferinject®/ Injectafer® demand impacted by global COVID-19 restrictions
  • Sustained growth in nephrology supported by dialysis business
  • Veltassa® net sales impacted by reduced promotion to nephrologists due to COVID-19
  • Etienne Jornod stepped down as Executive Chairman; Stefan Schulze appointed CEO of Vifor Pharma Group and Jacques Theurillat elected non-executive Chairman in...

    Continue Reading >

Health facilities booked for 5,000 coronavirus violations
August 5, 2020

RIYADH — Officials from the Ministry of Health have carried out 153,000 inspection tours health facilities in all regions of the Kingdom to monitor their compliance with precautionary measures and preventive protocols to stem the spread of coronavirus.

The ministry teams have so far registered 5,000 violations and referred them to the committees dealing with the violations and they also closed 150 establishments. However, most of the closed facilities"...

Continue Reading >

Saudi Arabia health care summit to accelerate global COVID-19 fight
August 4, 2020

RIYADH: Saudi Arabia will this month host one of the world’s largest health care summits that aims to unite global efforts against the coronavirus disease (COVID-19).

The event will bring together health care leaders and innovators from across the world to foster new collaborations and discuss the vital role of digital health in fighting pandemics.

Taking"...

Continue Reading >

Patient Safety Movement Foundation, the American Society of Anesthesiologists, The Leapfrog Group, and the International Society for Quality in Health Care Join Forces for #UniteForSafeCare World Patient Safety Day Campaign
August 4, 2020

Today, four leading global organizations dedicated to fighting preventable deaths due to medical errors announced their partnership to co-convene the #uniteforsafecare program on World Patient Safety Day (September 17, 2020). In June, the Patient Safety Movement Foundation announced the wide-ranging campaign to bring attention to system-wide improvements that will ensure better health worker and patient safety outcomes, called #uniteforsafecare. Now, the organization will be joined by the American Society of Anesthesiologists (ASA), The Leapfrog Group, and International Society for Quality in Health Care (ISQua) in co-convening the slate of programming, which includes a virtual physical challenge to raise awareness of the issue; collaboration with the National Association for Healthcare Quality’s......

Continue Reading >

'Health protocols put in place by KSA for Hajj 2020 won praise from WHO'
August 3, 2020

RIYADH — “Saudi Arabia made all the necessary preparations to ensure that Hajj is safe in many aspects, including health, definitely,” said Dr. Muhammad Al-Abdel Ali, Assistant Minister of Health and official spokesman for the Ministry of Health.

“The health protocols put in place by the Kingdom for Hajj 2020 matched international standards.”

“The extraordinary measures were adopted this year in the light"...

Continue Reading >

Takeda Announces FY2020 Q1 Results; Confirms Management Guidance & Raises Reported Operating Profit And Reported Net Profit for the Full Year
August 3, 2020

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2020 (quarter ended June 30, 2020). Based on the first quarter performance, the company confirms management guidance, and raises reported operating profit and reported net profit for the full year. The company also announced recent updates to its R&D pipeline and highlighted its R&D momentum with seven potential New Drug Application filings planned for the next 12 months. Underlying revenue growth was 0.9% year on year. Takeda’s five key business areas, which represent 83% of revenue, delivered underlying revenue growth of 6%, and its 14 global brands, with reported revenue of JPY 308.0 billion in aggregate, posted 20% underlying revenue......

Continue Reading >